AI Science Tracker
EN

Department of Nursing

2 discoveries from 2026

Discoveries

Construction of a machine learning-based risk prediction model for acute stroke in maintenance hemodialysis patients

Source check: Source checked. Not independent scientific confirmation.

Finding: A model developed from 1,100 maintenance-hemodialysis patients predicted acute stroke in a held-out 330-patient test set. XGBoost achieved AUC 0.847 (95% CI 0.791–0.902), sensitivity 0.73 and specificity 0.83. The study is single-center and retrospective; external validation and clinical benefit remain unestablished.

Technology: Seven machine-learning algorithms; XGBoost performed best

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Seven machine-learning algorithms were trained on clinical variables to estimate acute-stroke risk in maintenance-hemodialysis patients; XGBoost was the best-performing model.
Test and result
A single-center retrospective dataset of 1,100 patients was split into 770 training and 330 test cases. XGBoost achieved test AUC 0.847 (95% CI 0.791–0.902), sensitivity 0.73 and specificity 0.83.
Limitation / still unknown
The study reports no external validation or clinical-impact evaluation; performance beyond this held-out single-center cohort is unknown.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13769277/ · https://pubmed.ncbi.nlm.nih.gov/43034765/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Machine learning-based risk stratification for moderate-to-severe anxiety-depression in patients with hypertension and/or coronary heart disease: a multicenter cross-sectional study.

Source check: Source checked. Not independent scientific confirmation.

Finding: primary Methods/Results document the AI-enabled result, evaluation and bounded interpretation.

Technology: The named learned model operation is applied to the specific clinical/scientific endpoint and is linked to the result as described in the primary Methods/Results.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
to the specific clinical/scientific endpoint and is linked to the result as described in the primary Methods/Results
Test and result
Eight ML models risk-stratified PHQ-9/GAD-7 moderate/severe anxiety-depression among 4,006 hypertension/CHD survey respondents; RF test AUROC .838, Brier .134 and SHAP correlates. Full Methods/Results read. Cross-sectional self-report, internal-only validation; explicitly hypothesis-generating, not clinically ready
Limitation / still unknown
, endpoint/reference or comparator, and evaluation design/performance. Limitations are stated in the note; retrospective/internal/temporal validation is not represented as causal benefit or deployment
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13715117/ · https://pubmed.ncbi.nlm.nih.gov/42947157/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.